Albany Medical College, New York Oncology Hematology, PA, and Oncology Today
Last Modified: September 14, 2007
Conference Dates: September 27-28, 2007
Conference Location: Hilton Garden Inn at Albany Medical Center, Albany, New York
Sponsoring Group: Albany Medical College, New York Oncology Hematology, PA, and Oncology Today
Conference Web Page URL: http://www.nyohpc.com
Topics Covered: Oncologists are expected to assimilate a vast amount of rapidly evolving data on the latest cancer research and treatment developments. While the majority of translational research in oncology is conducted in the academic setting, most cancer patients receive care in their local communities. Practicing oncologists are therefore in particular need of educational opportunities that help them translate basic scientific advances into clinically useful information at the bedside.
The CME accredited conference Translational Medicine in Oncology: Bridging the Gap Between Basic Science and the Clinic offers a unique opportunity for academic and community-based oncologists and scientists involved in cancer research to interact and communicate fluently about the application of cutting-edge science to clinical situations. Nationally recognized experts in the field of translational oncology will present information and foster discussion focusing on the immediate clinical integration of scientific advances into the practice setting. Participants will take away practical information to assist in delivering the most effective cancer-fighting strategies for their patients.
Conference Objectives: At the conclusion of the program, the participant will be able to:
Who Should Attend: This continuing medical education program is intended for academic and community-based medical, surgical and radiation oncologists and hematologists, as well as basic scientists involved in cancer research.
Registration Information: For additional course information, please call Dawn Riggenbach at (281) 423.2683. Reference Translational Oncology meeting.
Conference Fees: $50 general; $25 for NYOH or AMC employees, FREE for students
Continuing Education: Yes
Jan 9, 2015 - A treatment strategy called bipolar androgen therapy -- where patients alternate between low and high levels of testosterone -- might make prostate tumors more responsive to standard hormonal therapy, according to a small study published in the Jan. 7 issue of Science Translational Medicine.
Aug 15, 2014
Feb 3, 2014